The BJP questioned the ‘seriousness’ of the Congress Government in investigating the phone tapping case and claimed that its own office staff as well as social media team were under the illegal mobile ...

Shares of Dr. Reddy's Laboratories Ltd. 500124 advanced 2.32% to 1,349.90 Indian rupees Tuesday, on what proved to be an all-around poor trading session for the stock market, with the BSE SENSEX ...

TPCC Chief, Min Ponnam meet MLA Malreddy Reddy; address concerns over cabinet expansion Hyderabad, June 9 (UNI) Telangana Pradesh Congress Committee (TPCC) President and MLC Mahesh Kumar Goud, along ...

Omission of Greater Hyderabad, Ranga Reddy could hurt the Congress party’s prospects in the upcoming local body elections says MLA Malreddy By Sistla Dakshina Murthy . Published on : 9 Jun 2025 8:07 ...

The highest paid director in India earns more than Sanjay Leela Bhansali, Karan Johar, Sandeep Reddy Vanga and Rohit Shetty. His next release will be in 2027.

MLA Malreddy said he is ready to quit if social equations block ministerial posts for Greater Hyderabad and Ranga Reddy, urging fair Cabinet representation ...

In recent trading, shares of Dr. Reddy's Laboratories Ltd. (Symbol: RDY) have crossed above the average analyst 12-month target price of $15.40, changing hands for $15.53/share. When a stock ...

On June 5, HSBC upgraded Dr. Reddy’s Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms ...

LIC’s shareholding in Dr. Reddy’s Laboratories rose from 5.6% at the end of September 2024 to 6.5% by December 2024, and further to 7.19% as of March 2025, according to the latest shareholding ...

Dr Reddy’s Laboratories announced that it has partnered with Alvotech, to co-develop, manufacture, and sell a biosimilar version of Keytruda (pembrolizumab), for global markets.

Alvotech (ALVO) and Dr. Reddy’s Laboratories (RDY) have entered into a collaboration and license agreement to co-develop, manufacture, and commercialize a biosimilar candidate to Keytruda ...

Under the agreement signed between the two companies, Alvotech and Dr. Reddy’s will be jointly responsible for developing and manufacturing the biosimilar candidate and sharing costs and ...